BANK OF AMERICA CORP /DE/
BankPosition in PRTA — Prothena Corp Public Ltd Co
CIK 70858
CHARLOTTE, NC
Position in PRTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,038,727
-$1,787,376 QoQ
Shares Held
208,246
-47.1% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Derivatives in PRTA
reported options exposure · as of Jun 30, 2023CallValue
$2,048,400
CallShares
30,000
PutValue
$614,520
PutShares
9,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. PRTA ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in PRTA
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,038,727 | 208,246 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,826,103 | 393,632 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,081,286 | 427,360 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,704,455 | 277,096 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,280,434 | 210,945 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,633,325 | 131,986 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,648,245 | 119,007 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,372,912 | 82,063 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,453,351 | 118,864 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,953,294 | 240,343 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,442,480 | 287,355 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,279,658 | 109,423 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,847,095 | 158,862 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $614,520 | 9,000 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $2,048,400 | 30,000 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $27,358,453 | 564,441 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,330,676 | 121,671 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,038,169 | 83,097 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,774,087 | 65,344 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,786,066 | 158,219 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,323,997 | 168,502 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,391,473 | 33,574 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $829,909 | 16,143 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,461,760 | 98,000 | Call | Defined | 2021-05-14 | |
| 2021-03-31 | $1,758,400 | 70,000 | Put | Defined | 2021-05-14 | |
| 2021-03-31 | $1,203,172 | 47,897 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $180,184 | 15,003 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $503,773 | 50,428 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $327,366 | 31,297 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $202,678 | 18,942 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||